Search results for " Conjugate"

showing 10 items of 111 documents

Optimizing strategies for meningococcal C disease vaccination in Valencia (Spain)

2014

Background: Meningococcal C (MenC) conjugate vaccines have controlled invasive diseases associated with this serogroup in countries where they are included in National Immunization Programs and also in an extensive catch-up program involving subjects up to 20 years of age. Catch-up was important, not only because it prevented disease in adolescents and young adults at risk, but also because it decreased transmission of the bacteria, since it was in this age group where the organism was circulating. Our objective is to develop a new vaccination schedule to achieve maximum seroprotection in these groups. Methods: A recent study has provided detailed age-structured information on the seroprote…

AdultMalePediatricsmedicine.medical_specialtyAdolescentVaccination scheduleMeningococcal VaccinesDiseaseBooster doseMeningococcal vaccineVaccination programsYoung AdultMeningococcal C conjugate vaccinesmedicineHumansYoung adultChildImmunization Programsbusiness.industryIncidence (epidemiology)VaccinationSeroprotection studyMiddle AgedAgent-based modellingMeningococcal InfectionsVaccinationInfectious DiseasesImmunizationSpainChild PreschoolFemaleMATEMATICA APLICADAbusinessResearch ArticleBMC Infectious Diseases
researchProduct

The potential role of 13-valent pneumococcal conjugate vaccine in preventing respiratory complications in bacteraemic pneumococcal community-acquired…

2015

Abstract Introduction Pneumococcal 13-valent vaccine (PCV-13) has a potential role in preventing bacteraemic pneumococcal pneumonia and its complications, but little is known about its ability to specifically prevent respiratory complications. Our aim were to analyse the pneumococcal serotypes associated with the development of respiratory complications and the potential role of PCV-13 in preventing respiratory complications in bacteraemic pneumococcal pneumonia. Material and methods We analysed demographic characteristics, comorbidities, antibiotic resistances and the outcomes of a cohort of 65 vaccine-naive bacteraemic pneumococcal pneumonias, stratified by the pneumococcal serotypes incl…

AdultMalemedicine.medical_specialtyPopulationBacteremiamedicine.disease_causeSerogroupPneumococcal conjugate vaccineHypoxemiaPneumococcal Vaccines03 medical and health sciences0302 clinical medicineCommunity-acquired pneumoniaInternal medicineStreptococcus pneumoniaemedicineHumans030212 general & internal medicineIntensive care medicineeducationAgedRetrospective StudiesAged 80 and overCOPDeducation.field_of_studyVaccines ConjugateGeneral VeterinaryGeneral Immunology and Microbiologybusiness.industryPublic Health Environmental and Occupational HealthMiddle AgedPneumonia Pneumococcalmedicine.diseaseCommunity-Acquired InfectionsPneumoniaInfectious DiseasesStreptococcus pneumoniae030228 respiratory systemPneumococcal pneumoniaMolecular MedicineFemalemedicine.symptombusinessmedicine.drugVaccine
researchProduct

Pneumococcus infections: Is the burden still as heavy?

2012

EA MERS CT3 Enjeu 3; International audience; The death rate of invasive pneumococcal infections decreased by 100 fold in one century. This tremendous improvement was due mainly to antibiotic use and multiple attempts at antipneumococcal vaccinations; thus, this was true only for developed countries. However, in France, the incidence has increased, over the last 10 years, in all age classes except for children vaccinated by the heptavalent pneumococcal conjugate vaccine. The incidence of these infections remains high, when associated to some risk factors such as HIV infection, malignant blood diseases, solid cancers, bronchial diseases, or alcohol abuse. The pneumococcal vaccine should be pr…

AdultSerotypeHeptavalent Pneumococcal Conjugate Vaccine[SDV]Life Sciences [q-bio]Immunization SecondaryAlcohol abuseGlobal HealthPneumococcal InfectionsPneumococcal Vaccines03 medical and health sciences0302 clinical medicineRisk FactorsHeptavalent Pneumococcal Conjugate Vaccine[SDV.BV]Life Sciences [q-bio]/Vegetal BiologyHumansMedicineserotype030212 general & internal medicineSerotypingChildinfection invasive à pneumocoque0303 health sciences030306 microbiologybusiness.industrypneumococcal invasive infectionDeveloped CountriesIncidenceMortality rateIncidence (epidemiology)VaccinationAge Factorssérotypemedicine.disease3. Good healthVaccinationPneumococcal infectionsStreptococcus pneumoniaeInfectious DiseasesPneumococcal vaccine[SDE]Environmental SciencesImmunologyDisease SusceptibilityFrancebusinessMédecine et Maladies Infectieuses
researchProduct

Comparison of concomitant outcome achieved with fresh and cryopreserved donor oocytes vitrified by the Cryotop method

2008

Objective To evaluate the outcome of oocyte vitrification using the Cryotop method, observed in an egg donation program by simultaneously evaluating embryos derived from vitrified and fresh oocytes coming from the same stimulated cycle. Design Cohort prospective randomized study. Setting Instituto Valenciano de Infertilidad (IVI) Valencia, Spain. Patient(s) Thirty oocyte donors and 30 recipients with informed consents. Intervention(s) Vitrification by the Cryotop method. Warming 1 hour after vitrification. Microinjection of surviving MII and fresh oocytes, evaluation of fertilization, embryo development, and clinical results. Main Outcome Measure(s) Survival, fertilization, and cleavage rat…

Adultmedicine.medical_specialtyAdolescentCell Culture TechniquesFertilization in VitroBiologyCryopreservationAndrologyHuman fertilizationPregnancymedicineHumansVitrificationBlastocystCryopreservationGynecologyEstrogens Conjugated (USP)EstradiolOocyte DonationPregnancy OutcomeObstetrics and GynecologyOocyte cryopreservationEmbryo TransferOocyteCulture MediaPregnancy ratemedicine.anatomical_structureReproductive MedicineFertilizationOocytesFemaleEmbryo qualityFertility and Sterility
researchProduct

Effect of oestrogen/gestagen replacement therapy on liver enzymes in patients with Ullrich-Turner syndrome.

1995

The absence of breast development and the prevention of osteoporosis in Ullrich-Turner syndrome (UTS) require oestrogen/gestagen substitution therapy. In 8 out of 35 (23%) patients with UTS treated with conjugated equine oestrogens and cyclically with norethisterone acetate, the serum liver enzymes increased to conspicuous levels (AST 35; 20-73 U/l, ALT 92; 37-141 U/l, GGT 77; 25-227 U/l, [median; min-max]). These findings were compared with those in 41 tall girls who received a six-fold larger dose of conjugated equine oestrogens for the reduction of final height. None of these 41 girls showed abnormal serum liver enzyme levels. The conspicuous rise in serum liver enzyme levels occurred in…

Adultmedicine.medical_specialtyAdolescentmedicine.drug_classmedicine.medical_treatmentOsteoporosisTurner SyndromeLiver Function TestsInternal medicineTurner syndromeBiopsymedicineHumansAspartate AminotransferasesSexual MaturationChildChemotherapyEstrogens Conjugated (USP)medicine.diagnostic_testbusiness.industryEstrogen Replacement TherapyAlanine Transaminasegamma-Glutamyltransferasemedicine.diseaseNorethisterone acetateBody HeightNorethindrone AcetateEndocrinologyEstrogenPediatrics Perinatology and Child HealthToxicityFemaleNorethindroneLiver function testsbusinessmedicine.drugFollow-Up StudiesEuropean journal of pediatrics
researchProduct

Folate-mediated targeting of polymeric conjugates of gemcitabine.

2005

The synthesis of two new macromolecular prodrugs for active tumor targeting was set up. Gemcitabine (2'-deoxy-2',2'-difluorocytidine) was conjugated to alpha,beta-poly(N-2-hydroxyethyl)-DL-aspartamide (PHEA) through succinyl or diglycolyl hydrolysable spacers. The targeting agent folic acid was attached to the macromolecular backbone through the aminocaproic spacer. The two conjugates [PHEA-(5'-succinylgemcitabine)-1'-carboxypentyl-folamide and PHEA-(5'-diglycolyl-gemcitabine)-1'-carboxypentyl-folamide], were purified and extensively characterised by spectroscopic (UV, IR and NMR) and chromatographic analyses to determine the correct chemical structure, the purity degree and the reaction yi…

Antimetabolites AntineoplasticTime FactorsStereochemistryCell SurvivalpolyaspartamideChemical structurePharmaceutical ScienceReceptors Cell SurfaceConjugated systemDeoxycytidineDrug Delivery SystemsFolic AcidCell Line Tumorfolate-mediated targetingExtracellularHumansProdrugsIncubationPolyhydroxyethyl MethacrylateDrug CarriersDose-Response Relationship DrugChemistrypolymeric conjugateFolate Receptors GPI-AnchoredSuccinatesHydrogen-Ion ConcentrationGemcitabineIn vitroBiochemistryCell cultureCarrier ProteinsMacromoleculeConjugateInternational journal of pharmaceutics
researchProduct

On a global superconvergence of the gradient of linear triangular elements

1987

Abstract We study a simple superconvergent scheme which recovers the gradient when solving a second-order elliptic problem in the plane by the usual linear elements. The recovered gradient globally approximates the true gradient even by one order of accuracy higher in the L 2 -norm than the piecewise constant gradient of the Ritz—Galerkin solution. A superconvergent approximation to the boundary flux is presented as well.

Applied MathematicsMathematical analysisOrder of accuracySuperconvergenceglobal superconvergence for the gradientComputer Science::Numerical AnalysisGlobal superconvergence for the gradientMathematics::Numerical AnalysisNonlinear conjugate gradient methodElliptic curveComputational Mathematicserror estimatesNorm (mathematics)boundary fluxPiecewisepost-processing of the Ritz—Galerkin schemeGradient descentGradient methodMathematicsJournal of Computational and Applied Mathematics
researchProduct

N-valproyl-aminoacids as new potential antiepileptic drugs: Synthesis, characterization and in vitro studies on stability

2015

Epilepsy, affecting at least 50 million persons worldwide, is one of the most common neurological disorders. Despite the significant advances in understanding epileptogenic mechanisms and in counteracting their pathological consequences, this clinical condition still has to be faced of treating more effectively the symptoms (epileptic seizures) and of preventing their unfavourable evolution. So far, research has been unsuccessful involved in developing effective antiepileptic drugs (AEDs) capable of preventing the development of the pathogenic process, set in motion by different etiological factors, that leads ultimately to chronic epilepsies .[1, 2] So, a substantial need remains to develo…

Biochemistry Genetics and Molecular Biology (all)Settore CHIM/09 - Farmaceutico Tecnologico ApplicativoBiochemistry (medical)Plant Scienceantiepileptic drugsAminoacidic conjugateBiochemistry Genetics and Molecular Biology (all); Biochemistry (medical); Plant ScienceValproyl derivative
researchProduct

Upregulation of liver VLDL receptor and FAT/CD36 expressions in LDLR-/- apoB100/100 mice fed trans-10,cis-12 conjugated linoleic acid

2006

International audience; This study explores the mechanisms responsible for the fatty liver setup in mice fed trans-10,cis-12 conjugated linoleic acid (t10c12 CLA), hypothesizing that an induction of low density lipoprotein receptor (LDLR) expression is associated with lipid accumulation. To this end, the effects of t10c12 CLA treatment on lipid parameters, serum lipoproteins, and expression of liver lipid receptors were measured in LDLR(-/-) apoB(100/100) mice as a model of human familial hypercholesterolemia itself depleted of LDLR. Mice were fed t10c12 CLA over 2 or 4 weeks. We first observed that the treatment induced liver steatosis, even in the absence of LDLR. Mice treated for 2 weeks…

CD36 AntigensMaleVery low-density lipoproteinTRANSLOCASECD36RECEPTEUR SCAVENGER[SDV]Life Sciences [q-bio]FATTY ACID TRANSLOCASE030204 cardiovascular system & hematologyBiochemistryMice0302 clinical medicineEndocrinologyLinoleic Acids ConjugatedMice Knockout0303 health sciencesLipoprotein lipaselipoprotéinebiologyacide grasrécepteur d'hormoneChemistryFatty liverFatty Acidsfood and beveragesHEPATIC LIPASELipidsLOW DENSITY LIPOPROTEIN RECEPTOR3. Good healthUp-RegulationLiverSCAVENGER RECEPTOR CLASS B TYPE ILIVER STEATOSIS;LOW DENSITY LIPOPROTEIN RECEPTOR;TRIGLYCERIDE;LIPOATROPHY;LIPOPROTEIN;FATTY ACID TRANSLOCASE;VERY LOW DENSITY LIPOPROTEIN RECEPTOR;HEPATIC LIPASE;LIPOPROTEIN LIPASE;LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN;SCAVENGER RECEPTOR CLASS B TYPE I;LIPOATROPHIE;TRANSLOCASE;LIPASE HEPATIQUE;RECEPTEUR SCAVENGERApolipoprotein B-100lipoprotéine lipaseTRIGLYCERIDElipids (amino acids peptides and proteins)Oxidation-Reductionmedicine.medical_specialtyLIPASE HEPATIQUELipolysisVLDL receptorMice Transgenicacide linoléique conjugué03 medical and health sciencesstéatose hépatiqueInternal medicineLIVER STEATOSISmedicineLIPOPROTEIN LIPASEAnimalsRNA Messengerlipoprotéine de faible densite030304 developmental biologyLOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEINnutritional and metabolic diseasesCell Biologymedicine.diseaseLipid MetabolismLIPOATROPHYDietary FatsEndocrinologyLIPOPROTEINReceptors LDLVERY LOW DENSITY LIPOPROTEIN RECEPTORLIPOATROPHIELDL receptorbiology.proteinacide gras transHepatic lipaseLipoprotein
researchProduct

Unequal rapidity correlators in the dilute limit of the JIMWLK evolution

2019

We study unequal rapidity correlators in the stochastic Langevin picture of Jalilian-Marian-Iancu-McLerran-Weigert-Leonidov-Kovner (JIMWLK) evolution in the color glass condensate effective field theory. We discuss a diagrammatic interpretation of the long-range con elators. By separately evolving the Wilson lines in the direct and complex conjugate amplitudes, we use the formalism to study two-particle production at large rapidity separations. We show that the evolution between the rapidities of the two produced particles can be expressed as a linear equation, even in the full nonlinear limit. We also show how the Langevin formalism for two-particle correlations reduces to a Balitsky-Fadin…

COLLISIONSPosition and momentum spacehiukkasfysiikkafield theory114 Physical sciences01 natural sciencesColor-glass condensatenuclear physicsINFINITE-MOMENTUM0103 physical sciencesEQUATIONEffective field theorySCATTERINGRapidity010306 general physicsMathematical physicsPhysicsComplex conjugate010308 nuclear & particles physicsStochastic processCOLOR GLASS CONDENSATENONLINEAR GLUON EVOLUTIONNonlinear systemDIPOLE PICTUREkvanttikenttäteoriaydinfysiikkaLinear equationPhysical Review D
researchProduct